have they ever published or presented the results for the IGA nepropathy group with the dimx asset? I've not been able to locate anything. if it's true the results were good as you say wonder why they went off into fsg disease rather than iga?
// iga n is where all the action and money is, like this one
https://www.novartis.com/news/media-releases/novartis-completes-acquisition-chinook-therapeutics
// that's a serious deal, and the FDA accept proteinuria here for accelerated approval in iga N which they don't for fsg
have they ever published or presented the results for the IGA...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.025(7.46%) |
Mkt cap ! $197.8M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.3¢ | 33.5¢ | $3.801M | 10.73M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 378856 | 6 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
36.0¢ |
Change
0.025 ( 7.33 %) |
||||
| Open | High | Low | Volume | ||
| 33.5¢ | 36.5¢ | 33.5¢ | 5557634 | ||
| Last updated 15.58pm 03/05/2024 ? | |||||
| DXB (ASX) Chart |